by Jordana Choucair | Dec 17, 2021 | Life Sciences
Regeneron Pharmaceuticals said its monoclonal antibody treatment for COVID-19 has “diminished potency” against the omicron variant but remains effective against delta. The drugmaker also said it is working on next-generation drugs that could protect...
by Jordana Choucair | Dec 17, 2021 | Life Sciences
The FDA said it will issue new guidance that will make abortion pills more accessible in some states, even after the pandemic. The move makes permanent pandemic-era guidance that allowed people to access the medication through telemedicine and receive the pills by...
by Jordana Choucair | Dec 17, 2021 | Life Sciences
The CDC has changed its recommendations for COVID-19 vaccines to clarify that mRNA vaccines are the preferred option over the Johnson & Johnson (J&J) vaccine. Although some members of the CDC advisory committee said the J&J vaccine should remain available...
by Jordana Choucair | Dec 17, 2021 | D.C. News
President Biden acknowledged that negotiations over his Build Back Better bill are poised to drag on into 2022 despite efforts to get it done before Christmas. “It takes time to finalize these agreements, prepare the legislative changes, and finish all the...
by Jordana Choucair | Dec 16, 2021 | Inequities and SDOH
Third Horizon Strategies (THS) announced the launch of The Health Equity Project – a national coalition of individuals, organizations, policy leaders, and investors seeking to transform the nation’s health care and social safety net systems to improve equitable access...
by Jordana Choucair | Dec 16, 2021 | Public Health/Prevention
Medical experts in the U.S. are bracing for a trio of threats this winter as flu and COVID-19 Omicron and Delta variant cases surge across the county. According to the CDC, between 837,000 and 845,000 people will have died by January 8. Federal health officials have...
Recent Comments